UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041046
Receipt number R000046870
Scientific Title Risk factors for endogenous peritonitis in patients on peritoneal dialysis
Date of disclosure of the study information 2020/07/09
Last modified on 2023/06/08 14:23:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Risk factors for endogenous peritonitis in patients on peritoneal dialysis

Acronym

Risk factors for endogenous peritonitis in patients on peritoneal dialysis

Scientific Title

Risk factors for endogenous peritonitis in patients on peritoneal dialysis

Scientific Title:Acronym

Risk factors for endogenous peritonitis in patients on peritoneal dialysis

Region

Japan


Condition

Condition

Chronic Renal Failure

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Anticipation and prevention of peritonitis in the treatment of PD patients is essential to improve the quality of care in the above context There is The present study was designed to investigate PD-related peritonitis in PD patients attending Nippon Medical School Hospital, which is usually The clinical characteristics obtained by the practice are investigated from the medical records. Then, trends and risk factors for endogenous peritonitis will be discussed to determine the The aim is to reduce endogenous peritonitis.

Basic objectives2

Others

Basic objectives -Others

Identification of risk factors for endogenous peritonitis

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Identification of risk factors for endogenous peritonitis

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients on peritoneal dialysis who attended Nippon Medical School Hospital from April 1, 2015 to March 31, 2020 and developed PD-related peritonitis

Key exclusion criteria

1)Patients deemed unsuitable for enrollment in this study by their physicians
2)Patients who could not give consent for this study

Target sample size

22


Research contact person

Name of lead principal investigator

1st name Yukinao
Middle name
Last name Sakai

Organization

Nippon Medical School Hospital

Division name

Department of Nephrology

Zip code

113-8603

Address

1-1-5 Sendagi, Bunkyo-ku, Tokyo

TEL

03-3822-2131

Email

y-sakai@nms.ac.jp


Public contact

Name of contact person

1st name Yukinao
Middle name
Last name Sakai

Organization

Nippon Medical School Hospital

Division name

Department of Nephrology

Zip code

113-8603

Address

1-1-5 Sendagi, Bunkyo-ku, Tokyo

TEL

03-3822-2131

Homepage URL


Email

y-sakai@nms.ac.jp


Sponsor or person

Institute

Nippon Medical School

Institute

Department

Personal name



Funding Source

Organization

Nippon Medical School

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical Council of Nippon Medical School Hospital

Address

1-1-5 Sendagi, Bunkyo-ku, Tokyo

Tel

03-3822-2131

Email

nms_fuzokurinri@nms.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 07 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

22

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 05 Month 16 Day

Date of IRB

2020 Year 07 Month 03 Day

Anticipated trial start date

2020 Year 07 Month 09 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

nothing in particular


Management information

Registered date

2020 Year 07 Month 09 Day

Last modified on

2023 Year 06 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046870


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name